Vaccines - Zimbabwe | Statista Market Forecast

The Vaccines market in Zimbabwe is estimated to generate a revenue of US$2.57m in 2024.
It is projected to exhibit a compound annual growth rate (CAGR) of 8.52% from 2024 to 2029, leading to a market volume of US$3.87m by 2029.
In terms of global comparison, United States is expected to generate the highest revenue of US$29.12bn in 2024.
Despite challenges such as limited healthcare infrastructure, Zimbabwe is making significant progress in increasing vaccine access and coverage to combat infectious diseases.

Definition:
This market covers vaccines against infectious diseases. They help to prevent diseases, usually through active immunization. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B or COVID-19) and bacteria (e.g., typhoid fever or meningococcus) are included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi, Moderna, AstraZeneca

Vaccines against infectious diseases
Prophylactic and therapeutic vaccines
Flu vaccines
COVID-19 vaccines

Sera and gammaglobulins
Antivirals
Antibiotics

The demand for vaccines in Zimbabwe has been on the rise in recent years, driven by several factors.

Customer preferences: Zimbabweans have become increasingly aware of the importance of vaccines in preventing diseases and promoting overall health. This has led to a growing demand for vaccines, particularly among parents who want to ensure their children are protected against common illnesses.

Trends in the market: One of the key trends in the vaccines market in Zimbabwe is the increasing availability of vaccines. The government has been working to expand access to vaccines, particularly in rural areas, where healthcare infrastructure is often limited. This has led to a greater number of people being vaccinated, which in turn has helped to reduce the incidence of vaccine-preventable diseases.Another trend in the market is the growing popularity of combination vaccines. These vaccines offer protection against multiple diseases in a single shot, making them more convenient for both patients and healthcare providers. As a result, they have become increasingly popular in Zimbabwe, particularly among children.

Local special circumstances: Zimbabwe has faced a number of challenges in recent years, including economic instability and political unrest. These factors have had an impact on the healthcare system, which has struggled to provide adequate care to all citizens. However, despite these challenges, the government has remained committed to expanding access to vaccines, recognizing the important role they play in promoting public health.

Underlying macroeconomic factors: The vaccines market in Zimbabwe is influenced by a number of macroeconomic factors, including government policies, healthcare spending, and international aid. The government has made significant investments in the healthcare system in recent years, including increasing funding for vaccines. Additionally, international organizations such as UNICEF and the World Health Organization have provided support for vaccine programs in Zimbabwe, helping to expand access to vaccines and improve overall health outcomes. Despite these positive developments, however, the vaccines market in Zimbabwe still faces significant challenges, including limited healthcare infrastructure and a shortage of healthcare workers.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

As of March 2023, more than 13 billion COVID-19 vaccine doses had been administered worldwide. Wide-spread vaccine availability, increasing herd immunity, and lower case numbers led to renewed hope and a feeling of normality in 2023. However, especially during the winter seasons and with the potential emergence of new variants of the virus (like Omicron in 2021-2022), tracking of coronavirus cases repeatedly becomes a focus for the public. Thus, there is a level of uncertainty about what developments the winter season 2023/2024 might bring.